Europe-Japan Diagnostic Study for EGFR Testing

CompletedOBSERVATIONAL
Enrollment

1,311

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.
Trial Locations (57)

Unknown

Research Site, Compiègne

Research Site, Gap

Research Site, Le Mans

Research Site, Longjumeau

Research Site, Meaux

Research Site, Saint-Brieuc

Research Site, Saint-Michel

Research Site, Saint-Quentin

Research Site, Villefranche-sur-Saône

Research Site, Buch

Research Site, Großhansdorf

Research Site, Halle

Research Site, Hamburg

Research Site, Hemer

Research Site, Karlsruhe

Research Site, Löwenstein

Research Site, Münnerstadt

Research Site, Nuremberg

Research Site, Solingen

Research Site, Bari

Research Site, Bologna

Research Site, Lecce

Research Site, Monza

Research Site, Napoli

Research Site, Orbassano (TO)

Research Site, Perugia

Research Site, Rome

Research Site, Hirakata

Research Site, Iizuka

Research Site, Kanazawa

Research Site, Mibu

Research Site, Nagasaki

Research Site, Nagoya

Research Site, Tokyo

Research Site, Toyonaka

Research Site, 's-Hertogenbosch

Research Site, Arnhem

Research Site, Bergen op Zoom

Research Site, Breda

Research Site, Nieuwegein

Research Site, Rotterdam

Research Site, Barcelona

Research Site, Burgos

Research Site, Cruces

Research Site, Donostia / San Sebastian

Research Site, León

Research Site, Madrid

Research Site, Pontevedra

Research Site, Gävle

Research Site, Karlstad

Research Site, Uppsala

Research Site, Cardiff

Research Site, Leeds

Research Site, Liverpool

Research Site, London

Research Site, Manchester

Research Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY